KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease.
Qiang ZhangYue ZhengMeng NingTong LiPublished in: BMC cardiovascular disorders (2021)
This study provided the screened seed genes, KLRD1, FOSL2 and LILRB3, as credible molecular biomarkers for plaques status changing in CAD progression and MI recurrence. Other seed genes, such as FOS, SOCS3 and MCL1, may also be potential targets for treatment due to their special clinical value in cardiovascular diseases.
Keyphrases
- coronary artery disease
- acute myocardial infarction
- percutaneous coronary intervention
- cardiovascular disease
- genome wide
- bioinformatics analysis
- genome wide identification
- coronary artery bypass grafting
- left ventricular
- heart failure
- type diabetes
- risk assessment
- metabolic syndrome
- human health
- free survival
- atrial fibrillation
- climate change
- transcription factor
- aortic stenosis